Our recent study demonstrated the attenuation of diastolic dysfunction and altered myocardial metabolism but no effect on apoptosis by pharmacological or genetic inhibition of FoxO1 in T2D mice [46]. This evidence concerns the gene FOXO1 and type 2 diabetes mellitus.